JG
CRMD icon

Joel Greenblatt’s CorMedix CRMD Stock Holding History

Joel Greenblatt’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Buy
22,400
+1,834
+9% +$14.5K ﹤0.01% 1741
2026
Q1 		$140K Sell
20,566
-4,609
-18% -$34.1K ﹤0.01% 1713
2025
Q4 		$293K Sell
25,175
-6,190
-20% -$68.4K ﹤0.01% 1569
2025
Q3 		$365K Buy
+31,365
New +$379K ﹤0.01% 1467

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Joel Greenblatt's CRMD Position: Q2 2026 in Review

Joel Greenblatt increased its CorMedix (CRMD) stake by 8.9% in Q2 2026, buying an estimated $14.5K and bringing the position to 22,400 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

Joel Greenblatt first reported a position in CRMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $365K in Q3 2025. 192 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Joel Greenblatt held 22,400 shares of CorMedix worth $176K as of Q2 2026.
  • Joel Greenblatt bought 1,834 CorMedix shares in Q2 2026, an estimated $14.5K.
  • CorMedix made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1741 holding.
  • Joel Greenblatt first reported a position in CorMedix in Q3 2025 and has held it in 4 quarters since.
  • Joel Greenblatt's CorMedix position peaked at $365K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.